Overview
Nathalie Rozensztajn practices practicing medicine in Paris, France.
Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nathalie Rozensztajn
Is Nathalie Rozensztajn a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Nathalie Rozensztajn is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nathalie Rozensztajn participate in research or clinical trials?
Yes. Nathalie Rozensztajn has published 9 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Nathalie Rozensztajn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMs. Rozensztajn isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung CancerMs. Rozensztajn isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Rozensztajn isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).